SABINE ROMAN: Open Payments
NPI 1043714520 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 48 payments from 15 companies in 2025. Trend: 2023 $396 · 2024 $988 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $226 |
| Amgen Inc. | 14 | $136 |
| GlaxoSmithKline, LLC. | 5 | $100 |
| SHIELD THERAPEUTICS INC | 2 | $93 |
| Novo Nordisk Inc | 4 | $75 |
| PFIZER INC. | 3 | $65 |
| Exact Sciences Corporation | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Lundbeck LLC | 1 | $26 |
Products named: KISUNLA, ACCRUFER, OTEZLA, TRELEGY ELLIPTA, PREVNAR 20, MOUNJARO, The Cologuard Plus Collection Kit, REXULTI.
Industry payments across TX — which companies pay providers there.
